KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Idexx Laboratories (IDXX) over the last 14 years, with Q1 2024 value amounting to $250000.0.

  • Idexx Laboratories' Asset Writedowns and Impairment changed N/A to $250000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $250000.0, marking a year-over-year decrease of 8315.36%. This contributed to the annual value of $250000.0 for FY2024, which is 8315.36% down from last year.
  • Per Idexx Laboratories' latest filing, its Asset Writedowns and Impairment stood at $250000.0 for Q1 2024.
  • Idexx Laboratories' 5-year Asset Writedowns and Impairment high stood at $2.0 million for Q3 2020, and its period low was $250000.0 during Q1 2024.
  • Its 4-year average for Asset Writedowns and Impairment is $1.1 million, with a median of $1.4 million in 2021.
  • Per our database at Business Quant, Idexx Laboratories' Asset Writedowns and Impairment crashed by 4752.07% in 2020 and then tumbled by 3211.24% in 2021.
  • Idexx Laboratories' Asset Writedowns and Impairment (Quarter) stood at $508000.0 in 2020, then skyrocketed by 166.34% to $1.4 million in 2021, then grew by 9.68% to $1.5 million in 2023, then plummeted by 83.15% to $250000.0 in 2024.
  • Its Asset Writedowns and Impairment was $250000.0 in Q1 2024, compared to $1.5 million in Q4 2023 and $1.4 million in Q3 2021.